Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $83.6 million.

  • Surgery Partners' Cash from Operations rose 2822.09% to $83.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $282.3 million, marking a year-over-year increase of 1233.59%. This contributed to the annual value of $300.1 million for FY2024, which is 214.43% up from last year.
  • Per Surgery Partners' latest filing, its Cash from Operations stood at $83.6 million for Q3 2025, which was up 2822.09% from $81.3 million recorded in Q2 2025.
  • Surgery Partners' Cash from Operations' 5-year high stood at $111.4 million during Q4 2024, with a 5-year trough of $2.3 million in Q2 2021.
  • Over the past 5 years, Surgery Partners' median Cash from Operations value was $52.1 million (recorded in 2023), while the average stood at $53.2 million.
  • In the last 5 years, Surgery Partners' Cash from Operations tumbled by 9873.56% in 2021 and then skyrocketed by 173043.48% in 2022.
  • Quarter analysis of 5 years shows Surgery Partners' Cash from Operations stood at $19.7 million in 2021, then plummeted by 63.45% to $7.2 million in 2022, then skyrocketed by 769.44% to $62.6 million in 2023, then skyrocketed by 77.96% to $111.4 million in 2024, then decreased by 24.96% to $83.6 million in 2025.
  • Its Cash from Operations was $83.6 million in Q3 2025, compared to $81.3 million in Q2 2025 and $6.0 million in Q1 2025.